Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A trial to investigate the efficacy and safety of methrotrexate in rheumatoid arthritis patients who switched from oral to subcutaneous methotrexate therapy

Trial Profile

A trial to investigate the efficacy and safety of methrotrexate in rheumatoid arthritis patients who switched from oral to subcutaneous methotrexate therapy

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 15 Jul 2014

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Methotrexate (Primary) ; Methotrexate (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Jul 2014 New trial record
    • 14 Jun 2014 Results presented at the 15th Annual Congress of the European League Against Rheumatism.
    • 20 May 2014 According to an Antares Pharma media release, the results of this trial will be presented at the 2014 European League Against Rheumatism Annual Congress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top